Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments

Barghorn, S., Mandelkow, E.·2002·Biochemistry
DOI 10.1021/bi026469j

Cited by (345)

Items 201–300 of 345

  1. Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain
    Bryan Frey, David Holzinger, Keenan C. Taylor, Dagmar E. Ehrnhoefer, Andreas Striebinger, Sandra Biesinger, Laura Gasparini, Michael J. O’Neill, Florian Wegner, Stefan Barghorn et al. · 2023 · Acta Neuropathologica Communications
  2. Alternative Conformations of the Tau Repeat Domain in Complex with an Engineered Binding Protein
    Clara S. R. Grüning, Ewa A. Mirecka, Antonia Nicole Klein, Eckhard Mandelkow�, Dieter Willbold, Stephen F. Marino, Matthias Stoldt, Wolfgang Hoyer · 2014 · Journal of Biological Chemistry
  3. The self-assembly ability of the first microtubule-binding repeat from tau and its modulation by phosphorylation
    Lian‐Xiu Zhou, Zhiyang Zeng, Jintang Du, Yufen Zhao, Yanmei Li · 2006 · Biochemical and Biophysical Research Communications
  4. Solid-state NMR investigation of the involvement of the P2 region in tau amyloid fibrils
    Adriana Savastano, Garima Jaipuria, Loren B. Andreas, Eckhard Mandelkow�, Markus Zweckstetter · 2020 · Scientific Reports
  5. Electrochemical Investigations into Kinase-Catalyzed Transformations of Tau Protein
    Meghan K. Rains, Sanela Martić, Daniel Freeman, Heinz‐Bernhard Kraatz · 2013 · ACS Chemical Neuroscience
  6. Taxol-stabilized microtubules promote the formation of filaments from unmodified full-length Tau in vitro
    Aranda R. Duan, Holly V. Goodson · 2012 · Molecular Biology of the Cell
  7. STED imaging of tau filaments in Alzheimer’s disease cortical grey matter
    Aleš Benda, Hayden Aitken, Danielle Davies, Renee Megan Whan, Claire S. Goldsbury · 2016 · Journal of Structural Biology
  8. A thiol-based intramolecular redox switch in four-repeat tau controls fibril assembly and disassembly
    Hilary A. Weismiller, Tyler J. Holub, Brad J. Krzesinski, Martin Margittai · 2021 · Journal of Biological Chemistry
  9. Neurodegeneration risk factor, EIF2AK3 (PERK), influences tau protein aggregation
    Goonho Park, Ke Xu, Leon Chea, Kyle Kim, Lance A. Safarta, Keon‐Hyoung Song, Jian Wu, Soyoung Park, Hyejung Min, Nobuhiko Hiramatsu et al. · 2022 · Journal of Biological Chemistry
  10. Tau Monoclonal Antibody Generation Based on Humanized Yeast Models
    Joëlle Rosseels, Jeff Van den Brande, Marie Violet, Dirk Jacobs, Pierre Grognet, Juan M. Lopez, Isabelle Huvent, Marina Caldara, Erwin Swinnen, Anthony Papegaey et al. · 2014 · Journal of Biological Chemistry
  11. Fluorescence-coupled CD conformational monitoring of filament formation of tau microtubule-binding repeat domain
    Fumie Mizushima, Katsuhiko Minoura, Koji Tomoo, Miho Sumida, Taizo Taniguchi, Toshimasa Ishida · 2006 · Biochemical and Biophysical Research Communications
  12. Pathological Impact of Tau Proteolytical Process on Neuronal and Mitochondrial Function: a Crucial Role in Alzheimer’s Disease
    Margrethe A. Olesen, Rodrigo A. Quintanilla · 2023 · Molecular Neurobiology
  13. Phosphorylation modulates the local conformation and self‐aggregation ability of a peptide from the fourth tau microtubule‐binding repeat
    Jintang Du, Chun‐Hui Yu, Lian‐Xiu Zhou, Wei‐Hui Wu, Peng Lei, Yong Li, Yufen Zhao, Hiroshi Nakanishi, Yanmei Li · 2007 · FEBS Journal
  14. Mercury(II) promotes the in vitro aggregation of tau fragment corresponding to the second repeat of microtubule‐binding domain: Coordination and conformational transition
    Danjing Yang, Shuo Shi, Leng‐Feng Zheng, Tianming Yao, Liang‐Nian Ji · 2010 · Biopolymers
  15. Modification of Tau by 8-Nitroguanosine 3′,5′-Cyclic Monophosphate (8-Nitro-cGMP)
    Jun Yoshitake, Yoshiyuki Soeda, Tomoaki Ida, Akio Sumioka, Misato Yoshikawa, Kenji Matsushita, Takaaki Akaike, Akihiko Takashima · 2016 · Journal of Biological Chemistry
  16. Effects of macromolecular crowding and osmolyte on human Tau fibrillation
    Yingying Wu, Ningning Teng, Sen Li · 2015 · International Journal of Biological Macromolecules
  17. Phosphorylation but Not Oligomerization Drives the Accumulation of Tau with Nucleoporin Nup98
    Lisa Diez, Larisa E. Kapinos, Janine Hochmair, Sabrina Hübschmann, Alvaro Dominguez‐Baquero, Amelie Vogt, Marija Rankovic, Markus Zweckstetter, Roderick Y. H. Lim, Susanne Wegmann · 2022 · International Journal of Molecular Sciences
  18. Solid-state NMR of paired helical filaments formed by the core tau fragment tau(297-391)
    Youssra K. Al‐Hilaly, Connor Hurt, Janet E. Rickard, Charles R. Harrington, John M. D. Storey, Claude M. Wischik, Louise C. Serpell, Ansgar B. Siemer · 2022 · Frontiers in Neuroscience
  19. Recent advances in experimental modeling of the assembly of tau filaments
    Li‐wen Ko, Michael A. Deture, Naruhiko Sahara, Rifki Chihab, Irving E. Vega, Shu-Hui C. Yen · 2004 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  20. In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening
    Rosa Crespo, Wouter Koudstaal, Adrian C. Apetri · 2018 · Journal of Visualized Experiments
  21. Intrinsically disordered proteins (IDPs) studied by EPR and in-cell EPR
    Sabrina Weickert, Julia Cattani, Malte Drescher · 2018 · Royal Society of Chemistry eBooks
  22. Molecular dynamics simulations to investigate the stability and aggregation behaviour of the amyloid-forming peptide VQIVYK from tau protein
    Jian-Hua Zhao, Hsuan‐Liang Liu, Chih‐Kuang Chuang, Kung-Tien Liu, Wei‐Bor Tsai, Yih Ho · 2010 · Molecular Simulation
  23. Preventing Disulfide Bond Formation Weakens Non-Covalent Forces among Lysozyme Aggregates
    Vijay Kumar Ravi, Mohit Goel, Hema Chandra Kotamarthi, Sri Rama Koti Ainavarapu, Rajaram Swaminathan · 2014 · PLoS ONE
  24. Development of tau PET Imaging Ligands and their Utility in Preclinical and Clinical Studies
    Yoori Choi, Seunggyun Ha, Yun‐Sang Lee, Yun Kyung Kim, Dong Soo Lee, Dong Jin Kim · 2017 · Nuclear Medicine and Molecular Imaging
  25. Structural evaluation of conformational transition state responsible for self-assembly of tau microtubule-binding domain
    Katsuhiko Minoura, Fumie Mizushima, Mari Tokimasa, Shuko Hiraoka, Koji Tomoo, Miho Sumida, Taizo Taniguchi, Toshimasa Ishida · 2005 · Biochemical and Biophysical Research Communications
  26. Shedding light on aberrant interactions – a review of modern tools for studying protein aggregates
    Franziska Kundel, Laura Tosatto, Daniel R. Whiten, David C. Wirthensohn, Mathew H. Horrocks, David Klenerman · 2018 · FEBS Journal
  27. Role of the p62 Protein in the Formation of Neuropathological Cytoplasmic Inclusions
    Erkki Kuusisto · 2004
  28. Role of the Cysteine in R3 Tau Peptide in Copper Binding and Reactivity
    Chiara Bacchella, Silvia Gentili, Sara Ida Mozzi, Enrico Monzani, Luigi Casella, Matteo Tegoni, Simone Dell’Acqua · 2022 · International Journal of Molecular Sciences
  29. Serotonergic dysfunction may mediate the relationship between alcohol consumption and Alzheimer’s disease
    Samantha R. Pierson, Louis John Kolling, Thomas D. James, Govindhasamy Pushpavathi Selvakumar, Catherine Anne Marcinkiewcz · 2024 · Pharmacological Research
  30. Neurotoxicity of oligomers of phosphorylated Tau protein carrying tauopathy-associated mutation is inhibited by prion protein
    Hanna Nieznańska, Solomiia Boyko, Robert Dec, Maria Jolanta Rędowicz, Wojciech Dzwolak, Krzysztof Nieznański · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  31. Vulnerabilities in the Tau Network and the Role of Ultrasensitive Points in Tau Pathophysiology
    Theresa M. Yuraszeck, Pierre A. Neveu, María Rodriguez-Fernández, Anne Skaja Robinson, Kenneth S. Kosik, Francis J. Doyle · 2010 · PLoS Computational Biology
  32. Conditionally inducible tau mice – designing a better mouse model of neurodegenerative diseases
    Christopher Janus · 2008 · Genes Brain & Behavior
  33. Native PLGA nanoparticles attenuate Aβ-seed induced tau aggregation under in vitro conditions: potential implication in Alzheimer’s disease pathology
    Pallabi Sil Paul, Tark Patel, Jae‐Young Cho, Allan Yarahmady, Aria Khalili, Valentyna Semenchenko, Holger Wille, Marianna Kulka, Sue‐Ann Mok, Satyabrata Kar · 2024 · Scientific Reports
  34. Therapeutic strategies for tauopathies and drug repurposing as a potential approach
    Majedul Islam, Fengyun Shen, Deepika Regmi, Deguo Du · 2022 · Biochemical Pharmacology
  35. Cooperative folding of tau peptide by coordination of group IIB metal cations during heparin-induced aggregation
    Danjing Yang, Shuo Shi, Tianming Yao, Liang‐Nian Ji · 2011 · BioMetals
  36. Novel demonstration of conformationally modified tau in sporadic inclusion-body myositis muscle fibers
    Anna Nogalska, Carla D’Agostino, W. King Engel, Valerie Askanas · 2011 · Neuroscience Letters
  37. Advanced imaging of tau pathology in Alzheimer Disease: New perspectives from super resolution microscopy and label‐free nanoscopy
    Gabriele S. Kaminski Schierle, Claire H. Michel, Laura Gasparini · 2016 · Microscopy Research and Technique
  38. Effect of altered solution conditions on tau conformational dynamics: Plausible implication on order propensity and aggregation
    Benita Jebarupa, Monita Muralidharan, Bindu Y. Srinivasu, Amit Kumar Mandal, Gopa Mitra · 2018 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  39. Cerebrospinal Fluid Biomarkers in Alzheimer Disease
    Douglas R Galasko · 2003 · Archives of Neurology
  40. MAP2 caps tau fibrils and inhibits aggregation
    Holden, Michael R., Krzesinski, Brad J., Weismiller, Hilary A., Shady, Justin R., Margittai, Martin · 2023 · Journal of Biological Chemistry
  41. The novel anti-fibrillary effects of volatile compounds α-asarone and β-caryophyllene on tau protein: Towards promising therapeutic agents for Alzheimer's disease
    Afrooz Anbaraki, Zahra Dindar, Zahra Mousavi-Jarrahi, Atiyeh Ghasemi, Zahra Moeini, Mina Evini, Ali Akbar Saboury, Arefeh Seyedarabi · 2024 · International Journal of Biological Macromolecules
  42. Tau peptides and tau mutant protein aggregation inhibition by cationic polyethyleneimine and polyarginine
    Keerthi Nadimidla, Tania Ismail, Mathumai Kanapathipillai · 2017 · Biopolymers
  43. The Underestimated Role of Iron in Frontotemporal Dementia: A Narrative Review
    Sara Ferretti, Isabella Zanella · 2024 · International Journal of Molecular Sciences
  44. Spontaneous Rupture and Entanglement of Human Neuronal Tau Protein Induced by Piconewton Compressive Force
    Susovan Roy Chowdhury, Hong Peter Lu · 2019 · ACS Chemical Neuroscience
  45. The C291R Tau Variant Forms Different Types of Protofibrils
    Thomas K. Karikari, Rachel Thomas, Kevin G. Moffat · 2020 · Frontiers in Molecular Neuroscience
  46. Site‐Specific Hyperphosphorylation Inhibits, Rather than Promotes, Tau Fibrillization, Seeding Capacity, and Its Microtubule Binding
    Mahmood Haj‐Yahya, Pushparathinam Gopinath, Kolla Rajasekhar, Hilda Mirbaha, Marc I. Diamond, Hilal Ahmed Lashuel · 2019 · Angewandte Chemie
  47. Tau Protein: Function and Pathology
    Hanna Rosenmann, David L Blum, Rakez Kayed, Lars Matthias Ittner · 2012 · International Journal of Alzheimer s Disease
  48. Cellular Uptake of Tau Aggregates Triggers Disulfide Bond Formation in Four-Repeat Tau Monomers
    Brad J. Krzesinski, Tyler J. Holub, Zachariah Y. Gabani, Martin Margittai · 2024 · ACS Chemical Neuroscience
  49. Extensive Plasmid Library to Prepare Tau Protein Variants and Study Their Functional Biochemistry
    Thomas K. Karikari, Sophie Keeling, Emily Hill, Juan Lantero‐Rodriguez, David A. Nagel, Bruno Becker, Kina Höglund, Henrik Zetterberg, Kaj Blennow, Eric James Hill et al. · 2020 · ACS Chemical Neuroscience
  50. Deciphering the Role of ATP on PHF6 Aggregation
    Saikat Pal, Rituparna Roy, Sandip Paul · 2022 · The Journal of Physical Chemistry B
  51. Clearance of the intracellular high level of the Tau protein directed by an artificial synthetic hydrolase
    Tingting Chu, Qian-Qian Li, Tian Qiu, Zhanyi Sun, Zhiwen Hu, Yong‐Xiang Chen, Yufen Zhao, Yanmei Li · 2014 · Molecular BioSystems
  52. Microglia express gamma-interferon-inducible lysosomal thiol reductase in the brains of Alzheimer's disease and Nasu-Hakola disease
    Jun‐ichi Satoh, Yoshihiro Kino, Motoaki Yanaizu, Tsuyoshi Ishida, Yuko Saito · 2018 · Intractable & Rare Diseases Research
  53. MAP2c prevents arachidonic acid-induced fibril formation of tau: Role of chaperone activity and phosphorylation
    Gopa Mitra, Suvroma Gupta, Asim Poddar, Bhabatarak Bhattacharyya · 2015 · Biophysical Chemistry
  54. Pin1: A New Outlook in Alzheimers Disease
    Elena Lonati, Massimo Masserini, Alessandra Bulbarelli · 2011 · Current Alzheimer Research
  55. Evidence for independent mechanisms and a multiple-hit model of tau assembly
    Michael A. Deture, Brian Granger, Andrew Grover, Mike Hutton, Shu-Hui C. Yen · 2005 · Biochemical and Biophysical Research Communications
  56. Inferring Mechanistic Parameters from Amyloid Formation Kinetics by Approximate Bayesian Computation
    Eri Nakatani-Webster, Abhinav Nath · 2017 · Biophysical Journal
  57. CSF metabolites associate with CSF tau and improve prediction of Alzheimer's disease status
    Ruocheng Dong, Burcu F. Darst, Yuetiva K. Deming, Yue Ma, Qiongshi Lu, Henrik Zetterberg, Kaj Blennow, Cynthia M. Carlsson, Sterling C. Johnson, Sanjay Asthana et al. · 2021 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  58. Tau Fibrillation Induced by Heparin or a Lysophospholipid Show Different Initial Oligomer Formation
    Helena Østergaard Rasmussen, Janni Nielsen, Angela de Poli, Daniel E. Otzen, Jan Skov Pedersen · 2023 · Journal of Molecular Biology
  59. The multifunctional dopamine D2/D3 receptor agonists also possess inhibitory activity against the full-length tau441 protein aggregation
    Iva Ziu, Irving D. Rettig, Dan Luo, Aloke K. Dutta, Theresa M. McCormick, Colin G. Wu, Sanela Martić · 2020 · Bioorganic & Medicinal Chemistry
  60. Cysteine in the R3 Tau Peptide Modulates Hemin Binding and Reactivity
    Chiara Bacchella, Teresa Benedetta Guerriere, Enrico Monzani, Simone Dell’Acqua · 2024 · Inorganic Chemistry
  61. Untangling the Complexity and Impact of Tau Protein Ubiquitination
    Daniele Trivellato, Francesca Munari, Michael Assfalg, Stefano Capaldi, Mariapina D’Onofrio · 2024 · ChemBioChem
  62. Dual roles of tau R peptides on Cu(II)/(I)-mediated reactive oxygen species formation
    Camilla Golec, Shaelyn Mortensen, Saba Anwar, Sanela Martić · 2021 · JBIC Journal of Biological Inorganic Chemistry
  63. The role of membranes in function and dysfunction of intrinsically disordered amyloidogenic proteins
    Bani Kumar Pathak, Sandip Dey, Sukanya Mozumder, Jayati Sengupta · 2022 · Advances in protein chemistry and structural biology
  64. Single Mutations in Tau Modulate the Populations of Fibril Conformers through Seed Selection
    Virginia Meyer, Paul D. Dinkel, Yin Luo, Xiang Yu, Guanghong Wei, Jie Zheng, Gareth R. Eaton, Buyong Ma, Ruth Nussinov, Sandra S. Eaton et al. · 2014 · Angewandte Chemie
  65. Understanding molecular features of aggregation-resistant tau conformer using oxidized monomer
    Benita Jebarupa, Boby Mathew, Bindu Y. Srinivasu, Aiswarya Sasikumaran, Smitha Joseph, Amit Kumar Mandal, Tinku S. Thomas, Gopa Mitra · 2019 · Biochimica et Biophysica Acta (BBA) - General Subjects
  66. Measuring Interactions Between Tau and Aggregation Inducers with Single-Molecule Förster Resonance Energy Transfer
    Sanjula P. Wickramasinghe, Elizabeth R. Rhoades · 2020 · Methods in molecular biology
  67. Visualization of Tau–Tubulin Interaction in a Living Cell Using Bifluorescence Complementation Technique
    Seulgi Shin, Sungsu Lim, Hyeanjeong Jeong, Li Ting Kwan, Yun Kyung Kim · 2018 · International Journal of Molecular Sciences
  68. The Impacts of Hg(II) Tightly Binding on the Alzheimer’s Tau Construct R3: Misfolding and Aggregation
    Danjing Yang, Shuo Shi, Tianming Yao, Liang‐Nian Ji · 2011 · Bulletin of the Chemical Society of Japan
  69. Development of a Fluorescent High Throughput Assay for Tau Aggregation
    Min Liu, Jake Ni, Kenneth S. Kosik, Li-An Yeh · 2004 · Assay and Drug Development Technologies
  70. Biomarkers in non-Alzheimer dementias
    Douglas R Galasko · 2004 · Clinical Neuroscience Research
  71. Concentration‐Based Analysis of Metal‐Induced Tau Fibrillar versus non‐fibrillar Aggregation: Implications for Neurotoxicity in Alzheimer's Disease
    Mahzad Irandoust, Afrooz Anbaraki, Zahra Dindar, Atiyeh Ghasemi, Ali Akbar Saboury, Saeed Rayati, Arefeh Seyedarabi · 2025 · ChemistryOpen
  72. Seeding biosensor cell line that reproduces the Alzheimer tau fold
    Taxiarchis Katsinelos, Sofia Lövestam, Chao Qi, Benjamin Falcon, Jennifer A. Macdonald, Gabriel Stephenson, Bernardino Francesco Ghetti, Ann Carolyn McKee, Sjors H. W. Scheres, Michel Goedert · 2025 · Journal of Biological Chemistry
  73. Big Tau: Structure, Evolutionary Divergence, and Emerging Roles in Cytoskeletal Dynamics and Tauopathies
    Itzhak Fischer, Peter W. Baas · 2026 · Cells
  74. Potential Protective Function of Aβ42 Monomer on Tauopathies
    Amber L. H. Gray, Victoria Norman, Damilola S. Oluwatoba, Rebecca A. Prosser, Thanh D. Do · 2023 · Journal of the American Society for Mass Spectrometry
  75. The Potential of Small Molecules in Preventing Tau Oligomer Formation and Toxicity
    Julia E. Gerson, Filippa Lo Cascio, Rakez Kayed · 2017 · Elsevier eBooks
  76. Purification of bovine Tau versions by affinity chromatography
    Daniela Volke, Ralf Hoffmann · 2006 · Protein Expression and Purification
  77. Passaging Human Tauopathy Patient Samples in Cells Generates Heterogeneous Fibrils with a Subpopulation Adopting Disease Folds
    Zhikai Zeng, Karen Tsay, Vishnu Vijayan, Matthew P. Frost, Shikhar Prakash, Athena Quddus, Alexa Albert, Michael P. Vigers, Madhur Srivastava, Amanda L. Woerman et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  78. Inhibiting Disulfide Bonding in Truncated Tau297–391 Results in Enhanced Self-Assembly of Tau into Seed-Competent Assemblies
    Sebastian Scott Oakley, Karen E. Marshall, Georg Meisl, Alice C. Copsey, Mahmoud Bukar Maina, Robert Milton, Thomas Vorley, John M. D. Storey, Charles R. Harrington, Claude M. Wischik et al. · 2025 · ACS Chemical Neuroscience
  79. Tau and Amyloid- Conformational Change to -Sheet Structures as Effectors in the Development of Alzheimer's Disease
    Martha A. De Anda-Hernández, Karla Isabel Lira-de León, Ra�l Mena, Victoria Campos‐Peña, Marco Antonio Meraz‐Ríos · 2012 · InTech eBooks
  80. The extracellular chaperone Clusterin enhances Tau aggregate seeding in a cellular model
    Patricia Yuste‐Checa, Victoria A. Trinkaus, Irene Riera-Tur, Rahmi Imamoglu, Theresa Schaller, Huping Wang, Irina Dudanova, Mark S. Hipp, Andreas Bracher, F. Ulrich Hartl · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  81. Central and peripheral tau retention modulated by an anti-tau antibody
    Alexander G. Solorzano, Molly Brady, Nemil N. Bhatt, Angelique Johnson, Brooke Burgess, Hannah Leyva, Nicha Puangmalai, Cynthia Jerez, Ronald W. Wood, Rakez Kayed et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  82. A high-throughput drug screening assay for anti-tau aggregation using split GFP and flow cytometry
    Omnia M. H. Ibrahium, Taiwo Ademola Ademoye, Jessica S. Fortin, Raluca Ostafe · 2025 · Scientific Reports
  83. Electric Double Layer Phenomena Near Surfaces Irreversibly Trigger Assembly of Tau Protein
    Eloïse Masquelier, Madeline H. Hicks, Nicholas B. Watkins, Norleakvisoth Lim, Justin Yi, Daniel E. Morse, Lior Sepunaru, Michael J. Gordon · 2026 · Journal of the American Chemical Society
  84. HMGB1 signalling in Alzheimer’s disease: pathogenic roles and therapeutic prospects
    Prashant Tyagi, Sneha Kumari, Prajjwal Sharma, Rishika Dhapola, Mohit Paidlewar, Bikash Medhi, Dibbanti HariKrishnaReddy · 2026 · International Immunopharmacology
  85. Neurodegenerative Diseases and Dementia
    Christopher Janus, Hans Welzl · 2016 · Springer eBooks
  86. Atomic Level Investigations of Early Aggregation of Tau43 in Water II . Tau43‐Aβ42 vs. Tau43‐ Tau43 Dimerizations
    Prathit Chatterjee, Myung Keun Cho, Huong Thi Bui, Sihyun Ham · 2021 · Bulletin of the Korean Chemical Society
  87. Tau-Centric Therapies for Treating Alzheimer’s Disease
    Shmma Quraishe, C.M. Cowan, Amritpal K. Mudher · 2017 · Elsevier eBooks
  88. Biochemical and biophysical features of disease-associated tau mutants V363A and V363I
    Ada De Luigi, Laura Colombo, Luca Russo, Caterina Ricci, Antonio Bastone, Sara Cimini, Fabrizio Tagliavini, Giacomina Rossi, Laura Cantú, Elena Del Favero et al. · 2022 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  89. Effect of PHF-1 hyperphosphorylation on the seeding activity of C-terminal Tau fragments
    Léa El Hajjar, Emmanuelle Boll, François‐Xavier Cantrelle, Clarisse Bridot, Isabelle Landrieu, Caroline Smet‐Nocca · 2025 · Scientific Reports
  90. Flavonoid-mediated modulation of Tau protein: Implications for targeted therapeutics and clinical relevance in Tau-related disorders
    Rayane Hedna, Emmanuelle T. Relave, Maxime Robin, Hervé Kovacic, Gilles Breuzard · 2025 · European Journal of Medicinal Chemistry Reports
  91. Tau Oligomers as Potential Drug Target for Alzheimer Disease (AD) Treatment
    Rakez Kayed · 2011 · InTech eBooks
  92. Nanoscale imaging of neurotoxic proteins
    Clemens F. Kaminski, Dorothea Pinotsi, Claire H. Michel, Gabriele S. Kaminski Schierle · 2014 · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE
  93. Polymorphism of Tau Fibrils
    Yoshiaki Furukawa · 2013 · Elsevier eBooks
  94. Spatial differences in gene expression across the dorsal raphe nucleus in a model of early Alzheimer's disease
    Louis John Kolling, Michael S. Chimenti, Catherine Anne Marcinkiewcz · 2024 · Journal of Alzheimer s Disease
  95. MIPAR and ImageJ FIJI as Tools for Electron Microscopy Quantification of Amyloid Fibrils
    Charles Garcia, Veena Prasad, T.C. Gamblin · 2025 · Biochemistry
  96. The Cellular Prion Protein as Universal Receptor for Amyloid Proteins
    Luigi Celauro, Giuseppe Legname · 2025 · The Receptors
  97. Tauopathy and Brain Aging
    A. Takashima · 2011 · Advances in neurobiology
  98. Experimental Models of Tau Aggregation
    Kerstin Buck, Thomas Robert Jahn, Laura Gasparini · 2018 · Elsevier eBooks
  99. Tau, Tangles and Tauopathies: Insights from Drosophila Disease Models
    Nisha Nisha, Pragati, Shweta Tandon, Aqsa Aqsa, Prerna Aggarwal, Surajit Sarkar · 2019 · Springer eBooks
  100. Probing Protein Aggregation Using the Coarse-Grained UNRES Force Field
    Ana V. Rojas, Gia G. Maisuradze, Harold A. Scheraga, Adam Liwo · 2022 · Methods in molecular biology